New drug shows promise in reducing COPD symptoms in smokers, clinical trials show
AstraZeneca said the drug cut moderate and severe flare-ups by 29% to 34% in late-stage trials of former and current smokers.
10 Articles
10 Articles
New drug shows promise in reducing COPD symptoms in smokers, clinical trials show - Regional Media News
(NEW YORK) - A new drug appeared to show promise in reducing rates of chronic obstructive pulmonary disease (COPD) symptoms in former and current smokers, according to results from late-stage clinical trials. The medication, called tozorakimab and developed by AstraZeneca, is the first biologic drug [...]
MyCentralOregon.com
New drug shows promise in reducing COPD symptoms in smokers, clinical trials show
A healthcare professional examines a chest X-ray displayed on a tablet. (Getty Images/Tom Werner) (NEW YORK) — A new drug appeared to show promise in reducing rates of chronic obstructive pulmonary disease (COPD) symptoms in former and
New drug shows promise in reducing COPD symptoms in smokers, clinical trials show - The Pulse of NH
A healthcare professional examines a chest X-ray displayed on a tablet. (Getty Images/Tom Werner)(NEW YORK) -- A new drug appeared to show promise in reducing rates of chronic obstructive pulmonary disease (COPD) symptoms in former and current smokers,...
Coverage Details
Bias Distribution
- 80% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
